Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Meelim J Lee"'
Autor:
Meelim J. Lee, Chuangqi Wang, Molly J. Carroll, Douglas K. Brubaker, Bradley T. Hyman, Douglas A. Lauffenburger
Publikováno v:
Frontiers in Neuroscience, Vol 15 (2021)
Mouse models are vital for preclinical research on Alzheimer’s disease (AD) pathobiology. Many traditional models are driven by autosomal dominant mutations identified from early onset AD genetics whereas late onset and sporadic forms of the diseas
Externí odkaz:
https://doaj.org/article/1a46203826334ebf9af29595514b0f95
Autor:
Liat Peretz Zats, Labiba Ahmad, Natania Casden, Meelim J Lee, Vitali Belzer, Orit Adato, Shaked Bar Cohen, Seung-Hyun B Ko, Mariella G Filbin, Ron Unger, Douglas A Lauffenburger, Rosalind A Segal, Oded Behar
Publikováno v:
Neuro-oncology advances. 4(1)
Background High-grade gliomas (HGG) in children have a devastating prognosis and occur in a remarkable spatiotemporal pattern. Diffuse midline gliomas (DMG), including diffuse intrinsic pontine gliomas (DIPG), typically occur in mid-childhood, while
Autor:
Diego Mastroeni, Douglas A. Lauffenburger, Forest M. White, Meelim J. Lee, Felicia H. Rodriguez, Nader Morshed
Alzheimer’s disease (AD) is a form of dementia characterized by amyloid-β plaques and tau neurofibrillary tangles that progressively disrupt neural circuits in the brain. The signaling networks underlying AD pathological changes are poorly charact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::649c870b6e13c1896f3ddd250192102a
https://doi.org/10.1101/2020.08.18.255778
https://doi.org/10.1101/2020.08.18.255778
Autor:
Kirsten Schneider, Martin Trapecar, Devon S. Svoboda, Douglas A. Lauffenburger, Samuel Mildrum, Meelim J. Lee, Rudolf Jaenisch, Linda G. Griffith, Austin Hendricks, Jason Velazquez, Julien Muffat, Pierre Sphabmixay, Stuart S. Levine, Emile Wogram, Attya Omer, David L. Trumper, Catherine Communal, Charles W. Wright, Tenzin Lungjangwa
Publikováno v:
Science Advances
Engineered model of the human gut-liver-brain axis can be used to study the link between the microbiome and Parkinson’s disease.
Slow progress in the fight against neurodegenerative diseases (NDs) motivates an urgent need for highly controlled
Slow progress in the fight against neurodegenerative diseases (NDs) motivates an urgent need for highly controlled